id,agency_id,title,docket_type,last_modified,object_id
FDA-1991-N-0191,FDA,"Civil money penalties:biologics, drugs and medical devices",Nonrulemaking,2026-02-27T22:02:58Z,0b0000648052de46
FDA-2000-M-0083,FDA,DACS SC Kit (Density Gradient Separation Medium),Nonrulemaking,2026-02-27T15:28:34Z,0b000064804b8053
FDA-2000-C-0236,FDA,Sodium Copper Chlorophyllin to Color Citrus Base Dry Beverage Mixes,Nonrulemaking,2026-02-24T15:58:14Z,0b000064804d5895
FDA-2000-N-0012,FDA,Request for Samples & Protocols; Agency Information Collection Activities,Nonrulemaking,2026-02-24T15:55:19Z,0b000064804ae876
FDA-2000-M-0120,FDA,PMA Defender II Model 9201 Implantable Cardioverter Defibrilator,Nonrulemaking,2026-02-24T14:46:29Z,0b000064804cf289
FDA-2000-N-0046,FDA,Importer's Entry Notice; Agency Information Collection Activities,Nonrulemaking,2026-02-24T14:43:05Z,0b000064804af15b
FDA-1981-N-0044,FDA,HYDROGEN PEROXIDE AS GRAS,Nonrulemaking,2026-02-24T14:29:07Z,0b000064805af2fb
FDA-1997-S-0006,FDA,"Dietary Supplements, Courtesy Letters (Letters of Objection)",Nonrulemaking,2026-02-20T19:22:56Z,0b000064805c957d
FDA-2004-N-0451,FDA,Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards,Nonrulemaking,2026-02-19T15:23:46Z,0b0000648047540d
FDA-2000-D-0104,FDA,"Conjugated Estrogens,USP-LC-MS Method for Qualitative Chemical",Nonrulemaking,2026-02-17T14:20:25Z,0b000064804c23c0
FDA-2000-F-0166,FDA,Components of Paper & Paperboard Incontact with Aqueous An,Nonrulemaking,2026-02-17T11:53:41Z,0b000064804d233a
FDA-2000-F-0056,FDA,"""Inhibitor of yeast"", for the Safe of (DMDC)",Nonrulemaking,2026-02-17T11:48:23Z,0b000064804af591
FDA-2000-F-0201,FDA,Olestra Be Amended Requirement for Label Statement,Nonrulemaking,2026-02-13T18:08:59Z,0b000064804d47b7
FDA-2000-V-1390,FDA,Request for Variance for Laser Light Show,Nonrulemaking,2026-02-13T18:04:52Z,0b000064804f0e42
FDA-2000-F-0055,FDA,Safe Use for X-Radiation & Electron Beam Energy Sources,Nonrulemaking,2026-02-13T15:47:36Z,0b000064804af54b
FDA-2000-P-0184,FDA,Totally Implanted Spinal Cord Stimulator,Nonrulemaking,2026-02-13T15:44:16Z,0b000064804d2a90
FDA-2000-D-0067,FDA,Medical Device Patient Labeling,Nonrulemaking,2026-02-13T15:32:46Z,0b000064804afceb
FDA-1981-N-0029,FDA,Sodium Chloride GRAS Safety,Nonrulemaking,2026-02-09T20:56:08Z,0b000064805af08d
FDA-1985-P-0507,FDA,ANDA SUIT RE: DIAZEPAM INTENSOL 5MG PER ML-CLOSED,Nonrulemaking,2026-02-09T15:46:15Z,0b000064805b79a1
FDA-2003-D-0431,FDA,Current Good Manufacturing Practices for Medical Gases,Nonrulemaking,2026-02-03T20:46:43Z,0b000064804a2255
FDA-2000-P-0211,FDA,Amend the Product Insert and/or Label for Anthrax Vaccine Adsorbed,Nonrulemaking,2026-02-03T15:25:23Z,0b000064804d4c7c
FDA-2000-N-0222,FDA,Dietary Supplement Health Claim/Implementation of Pearson Court Decision,Nonrulemaking,2026-01-30T18:32:47Z,0b000064804d51a5
FDA-2000-P-0756,FDA,ANADA Consisting of Different Physical Form of Drug Products,Nonrulemaking,2026-01-30T18:22:34Z,0b000064804e78ce
FDA-2000-P-0152,FDA,Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization,Nonrulemaking,2026-01-30T15:29:13Z,0b000064804d1186
FDA-2000-P-0414,FDA,Prozac (Fluoxetine Hydrochloride) 20 mg Tablets Voluntarily Withdrawn,Nonrulemaking,2026-01-30T15:25:11Z,0b000064804daeec
FDA-2000-M-0203,FDA,P990016; McCue CUBA Clinical Ultrasonic Bone Sonometry System,Nonrulemaking,2026-01-30T14:58:36Z,0b000064804d49d5
FDA-2000-P-1064,FDA,"To Amend 21 CFR 107 Subpart B, Labeling of Infant Formulas",Nonrulemaking,2026-01-26T14:08:58Z,0b000064804ecd04
FDA-2000-N-0048,FDA,Technical Implementation of Electronic Records & Electronic Signatures,Nonrulemaking,2026-01-23T14:19:52Z,0b000064804af199
FDA-2000-N-0165,FDA,Parasitic Infections in United States as Result of Raw Fish Consumption,Nonrulemaking,2026-01-23T14:16:11Z,0b000064804d22bf
FDA-2000-N-1571,FDA,Status of Useful Written Prescription Drug Information for Patients,Nonrulemaking,2026-01-23T13:56:21Z,0b00006480509235
FDA-2004-P-0153,FDA,Modification of 21 CFR Pt. 101.93 to Include Structure/Function ClaIms with Disclaimers that Eliminate Perceived Disease Connotations.,Nonrulemaking,2026-01-22T14:14:09Z,0b0000648046fff3
FDA-1999-D-2955,FDA,Impurities: Residual Solvents in New Veterinary Medicinal,Nonrulemaking,2026-01-21T15:43:17Z,0b000064804f26ac
FDA-2000-D-0420,FDA,Potency Limits for Standardized Dust Mite & Grass,Nonrulemaking,2026-01-13T14:10:40Z,0b000064804db107
FDA-2000-D-0160,FDA,M4 Common Technical Document; International Conference on Harmonisation,Nonrulemaking,2026-01-13T11:35:39Z,0b000064804d1829
FDA-2005-D-0460,FDA,Guidance for industry on Pediatric Drug Development Under the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act,Nonrulemaking,2026-01-08T15:22:32Z,0b00006480450aea
FDA-2000-P-0183,FDA,Request that FDA Not Approve Upjohn's Bovine Growth Hormone,Nonrulemaking,2026-01-06T18:45:26Z,0b000064804d2a11
FDA-2000-V-1073,FDA,Class IIIb requirements for the IZLID Series Laser Products,Nonrulemaking,2026-01-02T18:32:43Z,0b000064804ed086
FDA-2006-P-0207,FDA,Petition for Review of Codex Standard for Honey Under 21 CFR 130.6 - OPEN,Nonrulemaking,2026-01-02T14:33:19Z,0b0000648045151f
FDA-2003-D-0143,FDA,"Part11, Electronic records, electronic signatures scope",Nonrulemaking,2026-01-02T14:31:51Z,0b00006480486504
FDA-1998-D-0019,FDA,Investigating out of Specification(OOS)Test Results fr Pharm,Nonrulemaking,2026-01-02T14:26:42Z,0b00006480563cc6
FDA-2000-F-0115,FDA,Stabilizer in Olefin Polymers/Safe Use in Food Contact,Nonrulemaking,2025-12-19T13:47:19Z,0b000064804cf0d1
FDA-2000-N-0606,FDA,Psychiatric & Behavioral Disturbances Associated w/Dementia,Nonrulemaking,2025-12-19T13:31:02Z,0b000064804dd979
FDA-2000-N-0162,FDA,Amendment of Regulations Regarding Certain Label Statement of Prescription Drugs,Nonrulemaking,2025-12-19T13:21:00Z,0b000064804d1924
FDA-2000-D-0155,FDA,Reprocessing & Reuse of Single-Use Devices/Risk Categorization,Nonrulemaking,2025-12-16T14:25:22Z,0b000064804d14c1
FDA-2000-N-0191,FDA,Reclassification of the Knee Joint Patellofemorotibal Metal,Nonrulemaking,2025-12-16T12:26:32Z,0b000064804d41a2
FDA-2000-N-0106,FDA,Exemption from Federal Preemption of State & Local Medical,Nonrulemaking,2025-12-10T17:47:22Z,0b000064804c2509
FDA-1999-P-0001,FDA,Reclassification and Codification of Absorbable Polydioxanone Surgical Suture,Nonrulemaking,2025-12-09T13:24:03Z,0b000064804a58b4
FDA-1999-V-4085,FDA,Variance Laser Light Show,Nonrulemaking,2025-12-08T18:16:18Z,0b000064804f5ecd
FDA-1999-P-1852,FDA,Foods Derived from New Plant Varieties,Nonrulemaking,2025-12-08T14:11:39Z,0b000064804e7408
FDA-1999-D-0170,FDA,Health Claims for Conventional Foods & Dietary Supplements,Nonrulemaking,2025-12-02T14:33:32Z,0b000064804b039e
FDA-1992-V-0040,FDA,Laser effects for 'Fantasmic' show; CLOSED,Nonrulemaking,2025-11-20T16:05:21Z,0b00006480528933
FDA-1999-D-0045,FDA,Transmission of Zoonoses by Blood & Blood Products,Nonrulemaking,2025-11-18T17:42:41Z,0b000064804a5f5b
FDA-1999-P-0040,FDA,Amend limit Hydrogenated & partially Hydrogenated Menhaden Oil,Nonrulemaking,2025-11-18T14:53:35Z,0b000064804a5d9b
FDA-1999-F-4617,FDA,Food Safety & Inspection Service Safe Use of Ionizing Radiai,Nonrulemaking,2025-11-18T14:17:27Z,0b000064804f7562
FDA-1986-P-0035,FDA,EXCLUSIVE RIGHT TO DEPAKOTE (DIVALPROEX SODIUM)-CLOSED,Nonrulemaking,2025-11-06T14:10:33Z,0b0000648050e5c0
FDA-1999-E-0090,FDA,"Patent Term Extension Application for Isolex 300 and ISOLEX 300i, U.S. Patent No. 4,714,680",Nonrulemaking,2025-11-04T18:21:28Z,0b000064804a6a80
FDA-1999-E-0123,FDA,"Patent Term Extension for Uvadex, U.S. Patent No. 4,999,375",Nonrulemaking,2025-11-04T18:17:51Z,0b000064804ae990
FDA-1999-F-4619,FDA,Rubber Articles Intended for Use In Contact With Food,Nonrulemaking,2025-11-04T18:03:59Z,0b000064804f78db
FDA-1999-N-4097,FDA,Removal of Designed Journals Companion Document,Nonrulemaking,2025-10-28T14:21:33Z,0b000064804f5fc5
FDA-1999-N-0195,FDA,Amendment of Various Device Regulations,Nonrulemaking,2025-10-28T14:17:42Z,0b000064804b04fa
FDA-1999-P-0151,FDA,ANDA Suitability Petitions for Parenteral Drugs,Nonrulemaking,2025-10-28T12:49:14Z,0b000064804af144
FDA-1999-P-0127,FDA,"ANDA for Sterile Cefuroxime Sodium, USP",Nonrulemaking,2025-10-24T16:18:53Z,0b000064804aea02
FDA-1999-N-1323,FDA,Redacted Version of Substantially-Equivalent Premarket Notification,Nonrulemaking,2025-10-21T13:43:12Z,0b000064804db076
FDA-1999-P-4069,FDA,"ANDA for Naltrexone Hydrochloride Yablets for 25 100, &150mg",Nonrulemaking,2025-10-21T13:09:35Z,0b000064804f5e3f
FDA-1999-A-4057,FDA,Advisory Opinion Oxine(stabilized Chlorine Dioxide) in Sweetwater Systems,Nonrulemaking,2025-10-10T13:57:44Z,0b000064804f572f
FDA-1999-P-4073,FDA,ANDA for Propoxyphene Napsylate and Acetaminophen Tablets/Capsules 50mg,Nonrulemaking,2025-10-10T13:10:26Z,0b000064804f5e65
FDA-1994-N-0415,FDA,"Proposal to Debar Robert E. Sacher, Ph.D.",Nonrulemaking,2025-10-09T13:48:00Z,0b0000648050882a
FDA-1999-P-2918,FDA,Extend the Implementation Dates of the OTC Drug Labeling Rules,Nonrulemaking,2025-10-07T16:14:50Z,0b000064804f2302
FDA-1999-D-0062,FDA,New Use Food Contact Substance Notification Systems-Toxicolology,Nonrulemaking,2025-10-07T11:13:07Z,0b000064804a677c
FDA-1999-D-0066,FDA,Sampling & Microbial Testing of Spent Irrigation Water,Nonrulemaking,2025-09-30T12:59:56Z,0b000064804a67c4
FDA-2002-D-0188,FDA,Nonclinical Studies for Development of Pharmaceutical Excipi,Nonrulemaking,2025-09-24T16:24:59Z,0b000064804957bb
FDA-1995-N-0389,FDA,Fredrick Jay Shainfeld; Debarment Order,Nonrulemaking,2025-09-24T16:24:23Z,0b0000648059a4c9
FDA-1998-D-0038,FDA,Microbial Effects of Antimicrobial New Animal Drugs/Human Safety,Nonrulemaking,2025-09-23T12:57:57Z,0b00006480565cb1
FDA-2005-P-0280,FDA,To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations,Nonrulemaking,2025-09-23T12:35:31Z,0b00006480444a54
FDA-1999-F-0077,FDA,Safe Use of Solid Solution,Nonrulemaking,2025-09-23T11:20:23Z,0b000064804a68d2
FDA-1999-F-0056,FDA,National Fisheries Institute and the Louisiana Department of Agriculture,Nonrulemaking,2025-09-23T11:15:54Z,0b000064804a61b4
FDA-2000-D-0100,FDA,Clinical Data In Marketing Applications,Nonrulemaking,2025-09-22T15:08:05Z,0b000064804c2118
FDA-2003-D-0145,FDA,Draft Guidance: Sterile Drug Products Produced by Aseptic Processing,Nonrulemaking,2025-09-17T19:57:00Z,0b00006480486926
FDA-1999-M-0121,FDA,"PMA Medtronic Hancock II Bioprosthetic Heart Valve, Models T505, T510 & P980043",Nonrulemaking,2025-09-16T17:03:16Z,0b000064804ae967
FDA-1998-P-0083,FDA,Withdrawn From Sale of Tylosterone Tablets,Nonrulemaking,2025-09-10T18:33:30Z,0b00006480584ac8
FDA-2004-P-0212,FDA,"request the Commissioner of Food and Drugs to amend 21 CFR, Part 5.10) to request the Commissioner of Food and Drugs to amend 21 CFR, Part 101,subpart C: specific nutrition labeling  requirements and guidelines, specifically nutrition labeling of dietary supplements 101.36(d)(1), to require the source of the dietary ingredient lycopene to be indentified as from tomato,fungus, or synthetic",Nonrulemaking,2025-09-10T14:20:50Z,0b000064804710ac
FDA-1999-H-0071,FDA,Civil Money Penalty; Dong Seo Shin d/b/a East 4th Avenue Food Mart,Nonrulemaking,2025-09-09T18:05:21Z,0b000064804a6879
FDA-1999-N-0031,FDA,Positron Emmission Tomography Drug Products,Nonrulemaking,2025-09-05T13:51:16Z,0b000064804a5cdd
FDA-1999-P-2947,FDA,Determine if Neurontin (Gabapentin) Tablets 600mg & 800 Have Withdrawn,Nonrulemaking,2025-09-02T15:56:04Z,0b000064804f2668
FDA-1999-V-2946,FDA,Laser Light Show Mobolazer,Nonrulemaking,2025-09-02T14:26:18Z,0b000064804f2660
FDA-1999-P-0042,FDA,"Health Claim: Folic Acid, Vitamin B6 etc. & Vascular Disease",Nonrulemaking,2025-09-02T10:56:24Z,0b000064804a5e45
FDA-1999-F-0020,FDA,"Benzenepropanoic Acid, 3-5-bis(1,1-dimethylethy)-4-hydroxy-",Nonrulemaking,2025-08-29T13:57:43Z,0b000064804a5ab2
FDA-1999-F-0019,FDA,"Tridecanol Phosphite Butylidenebis[2-(1,-dimethylethy)-5-met",Nonrulemaking,2025-08-29T13:54:21Z,0b000064804a5aa1
FDA-2002-D-0223,FDA,Information for the use of Human Blood & Blood Components,Nonrulemaking,2025-08-28T17:04:27Z,0b00006480497176
FDA-1999-F-0102,FDA,Safe Use of Piperylene/2-methyl-2-butene/alpha-methylstyrene Terpolymers Use in Preparation of Can End Cements / Food Contact,Nonrulemaking,2025-08-26T13:11:30Z,0b000064804ae532
FDA-2001-D-0197,FDA,Statistical Approaches Establishing Bioequivalence,Nonrulemaking,2025-08-15T13:34:50Z,0b000064804e3068
FDA-2002-N-0325,FDA,Canned Tomatoes Deviating from Identity Standard,Nonrulemaking,2025-08-14T14:35:19Z,0b000064804a0b67
FDA-2005-P-0319,FDA,"Withhold Approval of any ANDA or any 505(b)(2) Application for any Generic Version or Other Pharmaceutical Alternative of Venofer(Iron Sucrose Injection, USP)",Nonrulemaking,2025-08-08T15:50:15Z,0b00006480447df4
FDA-2000-Q-0914,FDA,Notification for Health Claims:Potassium Containing Foods,Nonrulemaking,2025-08-08T12:10:26Z,0b000064804e8b31
FDA-2000-F-0147,FDA,Safe use of ozone in gaseous & aqueous phases as antimicrobi,Nonrulemaking,2025-08-08T12:09:19Z,0b000064804d0f8c
FDA-1999-N-1876,FDA,Blood Establishment Registration & Product Listing Form 2830,Nonrulemaking,2025-08-07T18:25:12Z,0b000064804e767e
FDA-1999-F-2413,FDA,Irradiate Animal Feeds/Feed Ingredients for Microbial Control,Nonrulemaking,2025-08-01T18:10:18Z,0b000064804f01c2
FDA-1999-P-0091,FDA,Adopt A Policy of Publicizing on the internet Certain Information,Nonrulemaking,2025-08-01T16:35:47Z,0b000064804a6a8d
FDA-1999-P-3513,FDA,ANDA Suitability Proposed a Dosage of Oxycodone and Acetaminophen Oral Solution,Nonrulemaking,2025-08-01T16:30:14Z,0b000064804f3ef0
FDA-1999-P-0125,FDA,Refuse Abbreviated New Drug Applications for Gabapentin Tablets,Nonrulemaking,2025-08-01T16:25:11Z,0b000064804ae9ba